A study in Cell Transplantation found type 2 diabetes patients who received autologous bone marrow stem cells required lower insulin doses compared with those in the control group. Longer-duration studies with a larger number of participants will be needed to establish the efficacy of stem cell treatment in diabetes, researchers said. Read more.
From now through July 31st when you visit your local Walgreens, you can support JDRF by making a donation of $1, $2, $5, or $10 at checkout. The dollars raised through this campaign will help JDRF create a world without T1D. Walgreens has supported JDRF for 20 years, contributing more than $20 million to JDRF's mission. Visit today!
A bipartisan U.S. House bill calls on HHS to create exercise guidelines for all Americans, based on scientific and medical knowledge, and update them every 10 years to promote healthy habits. The guidelines would include exercise recommendations for specific groups, such as children, and was submitted along with the FIT Kids Act, which would provide grant funding for school physical education and nutrition programs.
A new recommendation from the U.S. Preventive Services Task Force (USPSTF) advises all women to get screened for gestational diabetes after 24 weeks of pregnancy regardless of whether they have symptoms of the condition. Experts say the number of women developing the condition is on the rise as obesity, older maternal age and other risk factors become increasingly common. Read more.
Before you plan your next meal away from home, you may want to learn what researchers are learning about sit-down and fast food restaurants which may pose new threats to your waistline and overall health.
The UF Diabetes Center is pleased to welcome Eleni Polopolus Sheehan, BSN, RN, to our team. Eleni will serve as a clinical research coordinator and work on studies including the T1D Exchange and The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ms. Sheehan left a career in marketing and non-profit development to pursue a career in diabetes research and clinical care. Read more.
Researchers at the University of Minnesota have completed testing on an insulin-transplant technique which delivers pancreatic islet-cells from human donors to type 1 patients. If approved by the FDA, the pilot treatment could revolutionize existing treatment options for T1D patients by helping them remain insulin-free after five years. Read more.
Insulet's new OmniPod System, approved by the FDA is 34% smaller, 25% lighter and 16% slimmer. And although it's smaller, it still holds up to 200 units of insulin which can be worn continuously for up to three days. Learn how you can acquire your own.
UF Diabetes Researchers from the Department of Pathology, Immunology, and Laboratory Medicine participated in UF's First Annual Postdoctoral Research Symposium, sponsored by the Office of Postdoctoral Affairs and Office of the Provost. Their work highlights the latest progress being made in the advancement of type 1 diabetes research. Learn more.
A recent study co-authored by UF researcher Dr. Stephen Hsu identifies a "master protein" which may be the key to unlocking weight loss. By deleting the protein, mice in the study, became leaner -- even if they ate high-fat diets. While studies still need to be done in humans, scientists have unveiled a key biological mechanism underlying a problem: Two-thirds of U.S. adults are overweight or obese, as are one-third of children and teens. "If we treat obesity, the rationale is to prevent type 2 diabetes."